Vedolizumab (anti-α4β7-integrin)

Ask supplier a question | View on supplier's website

Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.

Supplier	Selleck Chemicals
Product #	A2045
Sku #	A2045-1mg*5
Pricing	1mg*5, $870.00

Feedback